DE3780446D1 - Verfahren zur feststellung von schwangerschaftsstoerungen. - Google Patents

Verfahren zur feststellung von schwangerschaftsstoerungen.

Info

Publication number
DE3780446D1
DE3780446D1 DE8787302547T DE3780446T DE3780446D1 DE 3780446 D1 DE3780446 D1 DE 3780446D1 DE 8787302547 T DE8787302547 T DE 8787302547T DE 3780446 T DE3780446 T DE 3780446T DE 3780446 D1 DE3780446 D1 DE 3780446D1
Authority
DE
Germany
Prior art keywords
protein
interventions
antibody
determining pregnancy
bound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8787302547T
Other languages
English (en)
Other versions
DE3780446T2 (de
Inventor
Michael Silberman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Diagnostic Technologies Ltd
Original Assignee
Technion Research and Development Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technion Research and Development Foundation Ltd filed Critical Technion Research and Development Foundation Ltd
Publication of DE3780446D1 publication Critical patent/DE3780446D1/de
Application granted granted Critical
Publication of DE3780446T2 publication Critical patent/DE3780446T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE8787302547T 1987-03-24 1987-03-24 Verfahren zur feststellung von schwangerschaftsstoerungen. Expired - Lifetime DE3780446T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP87302547A EP0283606B1 (de) 1987-03-24 1987-03-24 Verfahren zur Feststellung von Schwangerschaftsstörungen

Publications (2)

Publication Number Publication Date
DE3780446D1 true DE3780446D1 (de) 1992-08-20
DE3780446T2 DE3780446T2 (de) 1992-12-24

Family

ID=8197833

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787302547T Expired - Lifetime DE3780446T2 (de) 1987-03-24 1987-03-24 Verfahren zur feststellung von schwangerschaftsstoerungen.

Country Status (6)

Country Link
EP (1) EP0283606B1 (de)
AT (1) ATE78342T1 (de)
AU (1) AU599639B2 (de)
DE (1) DE3780446T2 (de)
ES (1) ES2033834T3 (de)
ZA (1) ZA872145B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021686A1 (en) 1993-03-19 1994-09-29 Northern Sydney Area Health Service Papp-a, its immunodetection and uses
US5783396A (en) * 1993-03-23 1998-07-21 Voroteliak; Victor Method of detecting rupture of the amniotic membranes in pregnant mammals
IL123098A0 (en) 1998-01-29 1998-09-24 Diagnostic Technologies Ltd Placental protein 13
IL129273A (en) 1999-03-30 2003-10-31 Diagnostic Technologies Ltd Monoclonal antibody to placental protein 13 and immunoassay and kit using said antibody
EP1537420B1 (de) 2002-08-29 2010-10-06 Diagnostic Technologies Ltd. Verfahren zur diagnose von schwangerschaftsstörungen
WO2023118979A1 (en) * 2021-12-22 2023-06-29 Novo Integrated Sciences Inc. System and method for antibody activators in an aqueous iodine solution

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3109629A1 (de) * 1981-03-13 1982-09-23 Behringwerke Ag, 3550 Marburg "neues protein (pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)6(pfeil abwaerts)), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung"
DE3230996A1 (de) * 1982-08-20 1984-02-23 Behringwerke Ag, 3550 Marburg Neues protein (pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)3(pfeil abwaerts)), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung
DE3338480A1 (de) * 1983-10-22 1985-05-02 Behringwerke Ag, 3550 Marburg Neues protein pp(pfeil abwaerts)2(pfeil abwaerts)(pfeil abwaerts)0(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung
AU6479986A (en) * 1985-10-22 1987-05-19 Murex Corp. Idiotypic-antigenic conjunction binding assay

Also Published As

Publication number Publication date
ZA872145B (en) 1988-09-26
ATE78342T1 (de) 1992-08-15
EP0283606A1 (de) 1988-09-28
EP0283606B1 (de) 1992-07-15
AU7059187A (en) 1988-09-22
DE3780446T2 (de) 1992-12-24
ES2033834T3 (es) 1993-04-01
AU599639B2 (en) 1990-07-26

Similar Documents

Publication Publication Date Title
Feigelson et al. Protein patterns of rabbit oviducal fluid
Thaler et al. Two tris urea mercaptoethanol extractable polypeptides found uniquely in scales of patients with psoriasis
ATE4127T1 (de) Testprobe zum messen von glukose.
DK557089D0 (da) Proeve for type iii collagennedbrydning
Langeland A Clinical and Immunological Study of Allergy to Hen's Egg White: II, Antigens in Hen's Egg White Studied by Crossed Immunoelectrophoresis (CIE)
Bennett The amino-terminal sequence of the heavy chain of human immunoglobulin M
DE3780446D1 (de) Verfahren zur feststellung von schwangerschaftsstoerungen.
Guenther et al. Identification of four extracellular-matrix enamel proteins during embryonic-rabbit tooth-organ development
Stevens et al. Immunochemical and electrophoretic properties of oestrous rabbit uterine fluid proteins obtained by uterine ligation
DE3850501D1 (de) MENSCHLICHES IgG GLYKOSYLATION-BESTIMMUNG.
Krøll Quantitative immunoelectrophoresis
DE69120463T2 (de) Verfahren zum Nachweis der Erythrozytenagglutination zur Feststellung der Blutverträglichkeit
Fletcher et al. Immunochemical studies of infectious mononucleosis II. Sodium dodecyl sulfate gel electrophoresis of membrane glycoprotein antigens
KR870005649A (ko) 고상화항체 및 그 제조방법
JPS6259783B2 (de)
Vidal et al. Immunological studies of bovine aorta lysyl oxidase: evidence for two forms of the enzyme
SE8205388L (sv) Forbettrad elektroforetisk metod for separering av serumproteiner och forbettrad elektroforetisk gel for anvendning dertill
DK0462115T3 (da) Diagnostisk proteinmarkør for blærecancer
SE7704359L (sv) Forfarande for anrikning av ett placentaspecifikt glykoprotein
Prause Immunoelectrophoretic determination of tear fluid proteins collected by the Schirmer I test
GB1151608A (en) A Method for Determining Vitamin B12
DE58906204D1 (de) Verfahren zur untersuchung von antikörpern spezifisch für rheumakrankheiten, insbesondere chronische polyarthritis sowie reagens hierfür.
Orren et al. Functional identification of serum complement components following electrophoresis in polyacrylamide gels containing sodium dodecyl sulphate
Maisel et al. Effect of urea on chick lens proteins
Hillier et al. Molecular heterogeneity of pregnancy-specific β1-glycoprotein (SP1)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DIAGNOSTIC TECHNOLOGIES LTD., HAIFA, IL

8328 Change in the person/name/address of the agent

Free format text: HAGEMANN & KEHL, 81675 MUENCHEN